Names & Terms You Will Hear
Plain-language meanings for the terms your care team may use.
| Term | Meaning |
|---|---|
| TAVR | Transcatheter Aortic Valve Replacement (US term we use) |
| TAVI | Transcatheter Aortic Valve Implantation (European / global term) |
| Percutaneous valve replacement | less common term, same procedure |
| Catheter-based aortic valve replacement | long-form description |
| BAV-then-TAVR | balloon valvuloplasty as a bridge before TAVR |
| SAVR | Surgical Aortic Valve Replacement — the open-heart alternative |
| Heart team | the group of cardiologists and surgeons who decide TAVR vs SAVR for you |
| Aortic stenosis (AS) | the underlying condition TAVR treats — a narrowed aortic valve |
What Is TAVR?
- TAVR places a new aortic valve through a small artery — usually in the groin — without opening your chest.
- The new valve is mounted on a wire frame (called a stent). It is delivered folded inside a thin tube (a catheter).
- Once positioned inside your old, narrowed valve, the new valve is expanded and takes over.
- The whole procedure usually takes 60–90 minutes. Most patients go home in 1–2 days.
- TAVR is done under conscious sedation or general anesthesia — your heart team decides what fits.
Why It Matters
- You have severe symptomatic AS confirmed by echocardiogram (and often a CT scan).
- Your heart team has reviewed your case. The team is required by national policy.
- Your anatomy is suitable — coronary heights, annulus size, peripheral artery diameter.
- Your overall health and other organ function support a procedure.
- Lower-risk patients now have TAVR as a guideline-supported option (2020 ACC/AHA VHD; PARTNER 3; Evolut Low Risk).
- Patients with bicuspid valves are increasingly treated with TAVR in experienced centers.
Treatment Options
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
- TAVR places a new aortic valve through a small artery — usually in the groin — without opening your chest.
- The new valve is mounted on a wire frame (called a stent). It is delivered folded inside a thin tube (a catheter).
- Once positioned inside your old, narrowed valve, the new valve is expanded and takes over.
- The whole procedure usually takes 60–90 minutes. Most patients go home in 1–2 days.
- TAVR is done under conscious sedation or general anesthesia — your heart team decides what fits.
- Day of procedure: You arrive early in the morning — nothing to eat or drink after midnight.
- Day of procedure: An IV is placed; you meet the heart team again. You sign final consent.
- Day of procedure: In the cath lab, sticky electrodes go on your chest; sterile drape covers most of your body.
- Day of procedure: Most patients receive conscious sedation (sleepy but breathing on your own). Some need general anesthesia.
- Day of procedure: The cardiologist accesses the femoral artery with a needle, then a wire and small tube.
- Day of procedure: The catheter carrying your new valve is advanced up to your aortic valve under X-ray guidance.
- Day of procedure: The valve is positioned and deployed (expanded). The team checks it works with imaging.
- Day of procedure: Catheters are removed. The artery is closed (suture, plug, or pressure).
- Day of procedure: You wake up in recovery. Most patients walk within 6 hours.
- Recovery: Hospital stay — usually 1 to 2 nights for transfemoral TAVR.
- Recovery: Activity — you can walk and do light activity right away. No heavy lifting (more than 10 lb) for 1 week.
- Recovery: Driving — most patients can drive in 3–5 days if not on narcotic pain medicine.
- Recovery: Showering — yes, the next day. Pat the access site dry; do not soak in a tub for 1 week.
- Recovery: Anticoagulation — most TAVR patients take a single antiplatelet (aspirin) for life. Some need a DOAC if AFib is present.
- Recovery: Cardiac rehab — supervised exercise program over 6–12 weeks. Improves recovery and lowers future events.
- Recovery: Follow-up echo — within 30 days, then yearly. Watches for valve function and any leak.
- Recovery: Return to work — most desk jobs in 3–7 days. Physical jobs in 2–4 weeks.
Risks, Benefits, and Alternatives
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
Every choice has trade-offs. Use this table to start the shared decision conversation with your care team.
| Option | Risks | Benefits | Alternatives |
|---|---|---|---|
| TAVR | Stroke (1–3%), pacemaker (5–15%, depends on valve), paravalvular leak, vascular complications, very rare valve embolization or coronary obstruction. Lifelong valve surveillance required. | No chest opening. Quicker recovery (1–2 days vs 5–7 days). Comparable mortality to SAVR at low risk through 5 years (PARTNER 3, Evolut Low Risk). Symptom relief usually within days. | SAVR (gold-standard durable repair, longer recovery), balloon valvuloplasty (palliative bridge only), conservative care if patient is not a candidate (poor prognosis). |
| SAVR (Open Surgery) | Stroke (similar overall to TAVR), bleeding requiring transfusion, atrial fibrillation post-op (~30%), longer hospital stay, sternal wound issues. | Direct visualization. Long-track-record durability data (decades). Allows concomitant CABG or other valve work in one operation. | TAVR (less invasive), staged procedures. |
| Balloon Aortic Valvuloplasty (BAV) | Restenosis within 6–12 months. Stroke. Vascular access complications. | Bridge to TAVR or SAVR in unstable patients. Sometimes used to test if symptoms will improve with valve work. | Direct TAVR if anatomy and stability allow. |
| Conservative care (no procedure) | Severe symptomatic AS without valve replacement carries about 50% mortality at 2 years. | Avoids procedure risk in the very few patients in whom procedure risk truly outweighs benefit. | TAVR or SAVR — almost always preferred when feasible. |
Common Misconceptions
| Myth | Reality |
|---|---|
| TAVR is just a quick procedure with no real risks. | TAVR is safer than open surgery for most patients but still carries stroke, pacemaker, and bleeding risks. The decision still belongs to a heart team. |
| Once I have TAVR I'm done — no follow-up. | TAVR requires lifelong follow-up. Annual echo, watch for new symptoms, and a single-pill antiplatelet (most often aspirin) is typical. |
| TAVR is only for very old or very sick patients. | TAVR is now an option across the risk spectrum. PARTNER 3 and Evolut Low Risk extended approval to low-risk patients in 2019. |
| Pacemaker after TAVR means TAVR failed. | A pacemaker is a known complication of TAVR — not a sign that TAVR did not work. The valve can function normally even with a pacemaker. |
| If I am asymptomatic, I do not need anything. | Some patients with very tight AS benefit from earlier valve replacement (RECOVERY trial). Talk with your cardiologist about timing. |
| Mechanical valves last forever, so TAVR must be worse. | TAVR uses tissue (bioprosthetic) valves. Tissue valves can wear out over years, but modern data show good durability and valve-in-valve TAVR is feasible. |
| I can stop my heart medicines after TAVR. | Blood pressure, cholesterol, and rhythm medicines usually continue. The valve is fixed; the rest of the cardiovascular system still needs care. |
| All TAVR valves are the same. | Two main families (balloon-expandable and self-expanding) have different strengths. Your heart team picks based on your anatomy. |
Possible Complications
Knowing what can go wrong helps you spot problems early. Most complications are uncommon, especially with treatment.
| Where / What | What Can Happen |
|---|---|
| Stroke | Brain blood-vessel blockage during or shortly after the procedure. — About 1–3% in low-risk PARTNER 3; lower with newer techniques and embolic protection in some centers. — Cerebral embolic protection device (Sentinel) when offered; aggressive BP and AFib management. |
| Pacemaker (LBBB or complete heart block) | The valve sits next to the heart's electrical wires; injury can trigger a slow rhythm needing a pacemaker. — 5–15%, varies by valve type and depth of implant. — ECG monitoring 1–3 days post-procedure; pacemaker if persistent block. |
| Paravalvular regurgitation (PVR) | Blood leaks around the new valve where it meets your old valve ring. — Mild PVR is common; moderate or severe is uncommon (< 5%) with modern valves. — Post-deployment ballooning, oversized valve, or rare valve-in-valve. |
| Vascular access complications | Bleeding, hematoma, or rare artery injury at the groin entry site. — Major: about 1–2%. Minor bruising: common. — Closure devices, ultrasound-guided puncture, surgical repair if needed. |
| Acute kidney injury | Drop in kidney function from contrast dye and procedural stress. — About 5%; usually transient. — Pre-hydration, contrast minimization, close labs after. |
| Valve thrombosis | Tiny clots can form on the new valve leaflets, sometimes silent. — Subclinical thrombosis: 5–15% on imaging at 1 year. — Surveillance echo; sometimes short-course anticoagulation. |
| Endocarditis | Infection of the new valve. — Less than 1% per year — same risk as SAVR. — Antibiotics before dental work; promptly evaluate fever after the procedure. |
| Structural valve degeneration | Wear and tear of valve leaflets over years. — 5- to 10-year durability data is favorable. Long-term (15+ years) data still maturing. — Annual echo; valve-in-valve TAVR if valve fails. |
Points to Know
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you remember nothing else, remember these key points.
- TAVR replaces the aortic valve through a small artery — no chest opening for most patients.
- TAVR is approved across all risk levels (low, intermediate, high). Heart team decides the best route.
- PARTNER 3 and Evolut Low Risk showed TAVR was non-inferior to surgery for low-risk patients at 2 years.
- Most patients go home in 1–2 days and return to normal activity in 1–2 weeks.
- Pacemaker is the most common 'expected' complication (5–15%); stroke is the most feared (1–3%).
- Lifelong follow-up matters: annual echo, single antiplatelet (often aspirin), report new symptoms early.
- Cardiac rehab improves recovery and outcomes — say yes if it is offered.
- If your dentist or another doctor schedules a procedure, tell them you have a prosthetic aortic valve.
When to Call Us — and When to Call 911
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you are not sure, call. We would rather hear from you twice than miss a real problem.
- Stroke symptoms (face droop, arm weakness, speech change) — call 911.
- New chest pain, severe shortness of breath, or fainting — call 911.
- Bleeding from the groin access site that does not stop with 10 minutes of pressure — call 911.
- Fever above 100.4°F more than 48 hours after the procedure — call us same day (rule out endocarditis).
- New irregular heartbeat, pounding, or skipped beats — call us within 24 hours.
- Leg pain, coolness, or color change in the access leg — call us within 24 hours.
- Pacemaker site swelling, redness, or pain — call us within 24 hours.
- Sudden weight gain (more than 3 lb overnight) or new ankle swelling — call us within 24 hours.
Office: (727) 943-5200
Trusted Resources
Independent, evidence-based pages we recommend for deeper reading.
- AHA — Heart Valve Problems and Disease — Plain-language overview of valve disease and treatments.
- Mayo Clinic — TAVR / TAVI — Comprehensive overview of TAVR with FAQs.
- Cleveland Clinic — TAVR — Procedure details and recovery information.
- STS Public Reporting (US TAVR Registry) — Hospital-level outcomes for TAVR programs in the US.
- Dr. Ali — Aortic Stenosis Patient Guide — The companion guide for full background on AS itself.
Sources Used to Build This Guide
- 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease (Otto et al., JACC 2021) [guideline] — Primary reference for the guide's aortic stenosis severity grading, intervention timing thresholds, and shared decision-making framework for TAVR vs. SAVR.
- PARTNER 3 — TAVR vs SAVR in Low-Risk Patients (Mack et al., NEJM 2019; PMID 30883058) [clinical_trial] — Foundational evidence cited in the guide's section explaining why TAVR is now a guideline-endorsed option for low-surgical-risk patients.
- Evolut Low Risk — Self-Expanding TAVR vs SAVR in Low-Risk Patients (Popma et al., NEJM 2019; PMID 30883053) [clinical_trial] — Supports the guide's explanation that self-expanding TAVR platforms are non-inferior to surgery in low-risk patients, reinforcing the PARTNER 3 finding.
- PARTNER 2A — TAVR vs SAVR in Intermediate-Risk Patients (Leon et al., NEJM 2016; PMID 27040324) [clinical_trial] — Evidence for the guide's historical timeline section showing TAVR expanded from high-risk to intermediate-risk patients based on non-inferiority data.
- PARTNER 1A — TAVR vs SAVR in High-Risk Patients (Smith et al., NEJM 2011; PMID 21639811) [clinical_trial] — Cited in the guide's origin story of TAVR as the first RCT to show TAVR was non-inferior to surgery in high-surgical-risk patients with severe AS.
- PARTNER 1B — TAVR vs Standard Care in Inoperable Patients (Leon et al., NEJM 2010; PMID 20961243) [clinical_trial] — Basis for the guide's section on patients who cannot have surgery, where TAVR reduced all-cause mortality by 46% compared with medical therapy.
- 2021 ESC/EACTS Guidelines for the Management of Valvular Heart Disease (Vahanian et al., Eur Heart J 2022) [guideline] — Provides the European perspective on TAVR indications and the Heart Team decision model referenced in the guide's 'Who Decides?' section.
- RECOVERY — Early Surgery vs Conservative Care in Asymptomatic Severe AS (Kang et al., NEJM 2020 [published online Nov 2019]; PMID 31733181) [clinical_trial] — Supports the guide's discussion of why watchful waiting in truly asymptomatic but very severe AS carries risk, and why early intervention may be considered.
- AHA — Heart Valve Problems and Disease (heart.org) [patient_education] — Recommended take-home reading for patients wanting a plain-language overview of how heart valves work and what happens when they become diseased.
- AHA — Aortic Stenosis: What You Need to Know (heart.org) [patient_education] — Cited in the guide's 'Understanding Your Diagnosis' section for patients wanting condition-specific information on aortic stenosis symptoms and treatment options.
